PANTHERx® Rare Continues Explosive Growth with Expansions of Pharmacy, HQ and Distribution Locations
April 25, 2024 PITTSBURGH – PANTHERx® Rare, the leader in rare disease pharmacy, patient access, and support services in the United...
Read More
PANTHERx® Rare Selected by Edenbridge Pharmaceuticals as Specialty Pharmacy for Yargesa® (miglustat 100 mg capsules)
April 1, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
PANTHERx® Rare Selected by Chiesi Global Rare Diseases for the Distribution of Filsuvez® (birch triterpenes) topical gel
February 7, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
PANTHERx® Rare Pharmacy Once Again Earns Top Ranking in Quarterly MMIT Patient Satisfaction Survey
December 7, 2023 PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual MMIT Patient Choice Award, once again, has...
Read More
PANTHERx® Selected by UCB as part of the Limited Specialty Pharmacy Network for RYSTIGGO® (rozanolixizumab-noli), for the Treatment of Generalized Myasthenia Gravis (gMG)
August 2, 2023 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
PANTHERx® Rare Announces Exciting Leadership Changes: New President and Key Hire
June 20, 2023 PITTSBURGH – PANTHERx® Rare, the nation’s leading rare disease pharmacy, is excited to announce significant...
Read More